Peer Review reports
From: Overexpression of DDX49 in prostate cancer is associated with poor prognosis
| Original Submission | ||
|---|---|---|
| 1 Nov 2022 | Submitted | Original manuscript |
| 21 Nov 2022 | Reviewed | Reviewer Report - Naresh Kumar Saidha |
| 12 Dec 2022 | Reviewed | Reviewer Report |
| 29 Dec 2022 | Reviewed | Reviewer Report - Simone Morra |
| 20 Jan 2023 | Reviewed | Reviewer Report |
| 21 Feb 2023 | Author responded | Author comments - Jun Zhou |
| Resubmission - Version 2 | ||
| 21 Feb 2023 | Submitted | Manuscript version 2 |
| 28 Feb 2023 | Author responded | Author comments - Jun Zhou |
| Resubmission - Version 3 | ||
| 28 Feb 2023 | Submitted | Manuscript version 3 |
| 15 Apr 2023 | Reviewed | Reviewer Report |
| Resubmission - Version 4 | ||
| Submitted | Manuscript version 4 | |
| Publishing | ||
| 18 Apr 2023 | Editorially accepted | |
| 27 Apr 2023 | Article published | 10.1186/s12894-023-01251-4 |
You can find further information about peer review here.